- In January 2024, Sichuan Jinjiang Electronic Medical Device Technology Co. Ltd. secured approval from China's National Medical Products Administration (NMPA) for its pulsed field ablation (PFA) technology designed for treating atrial fibrillation. This marks a significant milestone, as it becomes the first PFA device to receive commercial approval in China. The introduction of this innovative technology is expected to enhance treatment options for patients with atrial fibrillation in the region
- In April 2023, Fujifilm Healthcare Corporation announced the transfer of its electronic medical record (EMR) and medical receipt systems business to PHC Holdings Corporation. This move comes as part of a stock purchase agreement, positioning PHC Holdings, the parent company of Medicom medical information systems, to further enhance its offerings in healthcare technology. The transition aims to streamline operations and leverage synergies between the two organizations to better serve the medical community
- In October 2021, the Salk Institute initiated a phase 1 clinical trial to evaluate the safety of CMS121, a novel medication for Alzheimer's disease. This study aims to assess how the drug interacts with participants, providing crucial insights into its safety profile. The findings from this trial are expected to pave the way for further research into the medication's efficacy and potential applications in treating Alzheimer's
Frequently Asked Questions
The market is segmented based on Global Electro-Medical Devices in Alzheimer’s Treatment Market Segmentation, By Drug Class (Cholinergic, Memantine, Combined Drug, AChE Inhibitors, and Immunoglobulins), Drug Type (Cholinesterase Inhibitors and NMDA Receptor Antagonists), Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics) – Industry Trends and Forecast to 2031
.
The Global Electro Medical Devices In Alzheimers Treatment Market size was valued at USD 4.54 USD Billion in 2023.
The Global Electro Medical Devices In Alzheimers Treatment Market is projected to grow at a CAGR of 9.95% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
